MARKET

QTNT

QTNT

Quotient
NASDAQ
0.1516
-0.0162
-9.65%
Opening 14:01 09/29 EDT
OPEN
0.1628
PREV CLOSE
0.1678
HIGH
0.1657
LOW
0.1515
VOLUME
717.89K
TURNOVER
76.08K
52 WEEK HIGH
3.185
52 WEEK LOW
0.1418
MARKET CAP
20.59M
P/E (TTM)
-0.1140
1D
5D
1M
3M
1Y
5Y
Insiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20m
Insiders who acquired US$414k worth of Quotient Limited's ( NASDAQ:QTNT ) stock at an average price of US$0.33 in the...
Simply Wall St. · 1d ago
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Benzinga · 09/16 16:38
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 09/16 12:20
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Investor Place · 09/16 11:27
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.
Benzinga · 09/16 10:35
Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket
Gainers Infobird Co., Ltd (NASDAQ: IFBD) rose 70.8% to $3.16 in pre-market trading after 1:5 reverse stock split takes effect.
Benzinga · 09/09 10:35
Quotient Limited Selected to Join the World Economic Forum New Champions Community
The World Economic Forum’s New Champions Community brings together purpose driven companies of mid-size whose leadership is mindful of their impact on society and aspiring in building a better future​These companies champion new business models and technol...
GlobeNewswire · 09/08 12:30
Quotient Reported Late Tuesday In Form4 Filing Director Buys 100K Shares At Average Price Of $0.18/Share
-SEC Filing
Benzinga · 09/07 13:16
More
About QTNT
Quotient Limited is a Switzerland-based diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Webull offers kinds of Quotient Ltd stock information, including NASDAQ:QTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QTNT stock methods without spending real money on the virtual paper trading platform.